Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Farber Lipogranulomatosis D055577 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Ratner M Novartis eyes oral MS drug as potential blockbuster. 2010 Nat. Biotechnol. pmid:21057464
Ponnusamy S et al. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. 2010 Future Oncol pmid:21062159
Dhami R et al. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. 2010 Cell. Physiol. Biochem. pmid:21063112
Fox TE et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. 2011 J. Lipid Res. pmid:21068007
Wang L et al. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. 2011 Eur. Respir. J. pmid:21071472
Siow DL et al. Sphingosine kinase localization in the control of sphingolipid metabolism. 2011 Adv. Enzyme Regul. pmid:21075134
Jang S et al. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. 2011 Neurochem. Res. pmid:21076868
Hirahara K et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. 2010 Cytokine Growth Factor Rev. pmid:21084214
Hisano Y et al. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. 2011 J. Biol. Chem. pmid:21084291
Muscoli C et al. Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. 2010 J. Neurosci. pmid:21084596
Lai WQ et al. Sphingosine kinase and sphingosine 1-phosphate in asthma. 2011 Biosci. Rep. pmid:21091442
Sabbadini RA Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. 2011 Br. J. Pharmacol. pmid:21091645
Howard C et al. Dental pulp stem cell migration. 2010 J Endod pmid:21092813
Majeed Y et al. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. 2011 Br. J. Pharmacol. pmid:21108630
Kikuta J et al. S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. 2011 Rheumatol. Int. pmid:21113810
Hu PF et al. Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis. 2011 Mol. Biol. Rep. pmid:21116853
Bonnaud S et al. Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. 2010 Cancer Res. pmid:21118968
Ishii M et al. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. 2010 J. Exp. Med. pmid:21135136
Bieberich E There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. 2011 Neurochem. Res. pmid:21136155
Cho MC et al. Involvement of sphingosine-1-phosphate/RhoA/Rho-kinase signaling pathway in corporal fibrosis following cavernous nerve injury in male rats. 2011 J Sex Med pmid:21143420
Li C et al. Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. 2011 J. Hepatol. pmid:21145832
Zhao Y et al. Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21148740
Jeffery DR et al. Fingolimod for the treatment of relapsing multiple sclerosis. 2011 Expert Rev Neurother pmid:21158700
Chi H Sphingosine-1-phosphate and immune regulation: trafficking and beyond. 2011 Trends Pharmacol. Sci. pmid:21159389
Jee BC et al. Dose-dependent effect of sphingosine-1-phosphate in mouse oocyte maturation medium on subsequent embryo development. 2011 Gynecol. Obstet. Invest. pmid:21160167
Ter Braak M et al. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator. 2011 Biochem. Pharmacol. pmid:21163254
Markiewicz M et al. Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. 2011 Microcirculation pmid:21166920
Zhao M et al. [The effects of sphingosine-1 1-phosphate (SIP) on the action potential and contractile in guinea pig ventricular myocardium]. 2007 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21171361
Allende ML et al. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. 2011 J. Biol. Chem. pmid:21173151
Duan HF et al. [Establishment of a method for determining the sphingosine kinase activity and its initial application]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21180179
Zhao M et al. [The effects of Sphing-1-phosphate(S1P) on the potassium channel of the ventricular myocytes]. 2009 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21186617
Sassoli C et al. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. 2011 J. Cell. Mol. Med. pmid:21199328
Kim YM et al. G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. 2011 Arterioscler. Thromb. Vasc. Biol. pmid:21212405
Kharel Y et al. A rapid assay for assessment of sphingosine kinase inhibitors and substrates. 2011 Anal. Biochem. pmid:21216217
Gaveglio VL et al. Metabolic pathways for the degradation of phosphatidic acid in isolated nuclei from cerebellar cells. 2011 Arch. Biochem. Biophys. pmid:21216221
Doyle T et al. Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats. 2011 Pain pmid:21239112
Bouma HR et al. Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21245336
Aarthi JJ et al. Dissecting the role of the S1P/S1PR axis in health and disease. 2011 J. Dent. Res. pmid:21248363
Ulrych T et al. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. 2011 J. Thromb. Haemost. pmid:21251196
Catarzi S et al. Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. 2011 Biochim. Biophys. Acta pmid:21256191
Dickson MA et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. 2011 Clin. Cancer Res. pmid:21257722
Beljanski V et al. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. 2011 Cancer Biol. Ther. pmid:21258214
Bolli MH et al. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls. 2011 Curr Top Med Chem pmid:21261590
Hopson KP et al. S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. 2011 Am. J. Physiol., Cell Physiol. pmid:21270296
Lee SY et al. Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice. 2011 Nephrology (Carlton) pmid:21272128
Herzog C et al. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. 2010 Mediators Inflamm. pmid:21274265
Sumida GM and Stamer WD S1Pâ‚‚ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology. 2011 Am. J. Physiol., Cell Physiol. pmid:21289286
Sensken SC et al. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia. 2011 J. Immunol. pmid:21289303
Lan T et al. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21292568
McQuiston T et al. Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. 2011 Microbiology (Reading, Engl.) pmid:21292747
Highkin MK et al. High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. 2011 J Biomol Screen pmid:21297110
Ding R et al. Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase. 2012 Inflammation pmid:21302134
Berdyshev EV et al. Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. 2011 PLoS ONE pmid:21304987
Schuchardt M et al. Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. 2011 Br. J. Pharmacol. pmid:21309759
López-Juárez A et al. Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. 2011 Glia pmid:21319224
Yonamine I et al. Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. 2011 J. Cell Biol. pmid:21321100
Hagen N et al. Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. 2011 Cell Death Differ. pmid:21331079
Bandhuvula P et al. S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21335477
Jenkins RW et al. Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. 2011 J. Biol. Chem. pmid:21335555
Törnquist K Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. 2012 Acta Physiol (Oxf) pmid:21338471
Pinschewer DD et al. Impact of sphingosine 1-phosphate modulation on immune outcomes. 2011 Neurology pmid:21339486
Mehling M et al. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. 2011 Neurology pmid:21339487
Hla T and Brinkmann V Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. 2011 Neurology pmid:21339489
Soliven B et al. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. 2011 Neurology pmid:21339490
Serebrov VIu et al. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. 2010 Mar-Apr Biomed Khim pmid:21341516
Ruiz-Medina J et al. GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception. 2011 Jul-Aug Neuropharmacology pmid:21352831
Kikuta J et al. [Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. 2011 Clin Calcium pmid:21358058
Mair N et al. Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. 2011 PLoS ONE pmid:21359147
Ishii T et al. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. 2011 Mol. Cells pmid:21360199
Antel J and Hohlfeld R Modulation of sphingosine 1-phosphate signaling in neurologic disease. 2011 Neurology pmid:21360856
Jung M et al. Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. 2011 Exp. Dermatol. pmid:21366697
Kumar A et al. S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. 2011 Cell Death Dis pmid:21368890
Yogi A et al. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. 2011 Hypertension pmid:21383307
Sánchez BA et al. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. 2011 Anal Bioanal Chem pmid:21394454
Lamana A et al. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. 2011 J. Invest. Dermatol. pmid:21412255
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Roviezzo F et al. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. 2011 J. Pharmacol. Exp. Ther. pmid:21421740
Ocaña-Morgner C et al. Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. 2011 J. Immunol. pmid:21421853
Kato K et al. Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. 2011 Endocrinology pmid:21427224
Schröder M et al. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. 2011 Mol. Immunol. pmid:21435724
Kujjo LL et al. Chemotherapy-induced late transgenerational effects in mice. 2011 PLoS ONE pmid:21437292
Cahalan SM et al. Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice. 2011 Nat. Chem. Biol. pmid:21445057
Brecht K et al. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. 2011 FASEB J. pmid:21450910
Lim KG et al. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. 2011 J. Biol. Chem. pmid:21464128
Zhu Q et al. A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. 2011 Am. J. Physiol. Renal Physiol. pmid:21478479
Kennedy AJ et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. 2011 J. Med. Chem. pmid:21495716
Kartal M et al. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. 2011 Nutr Cancer pmid:21500096
Jackson EK Role of sphingosine-1-phosphate in the renal medulla. 2011 Am. J. Physiol. Renal Physiol. pmid:21511695
Pyne S and Pyne NJ Translational aspects of sphingosine 1-phosphate biology. 2011 Trends Mol Med pmid:21514226
Cohen JA and Chun J Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. 2011 Ann. Neurol. pmid:21520239
Salas A et al. Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. 2011 Blood pmid:21527515
Baranowski M et al. Exercise increases plasma levels of sphingoid base-1 phosphates in humans. 2011 Acta Physiol (Oxf) pmid:21535416
Takasugi N et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. 2011 J. Neurosci. pmid:21543615
Separovic D et al. Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitization. 2011 Biochem. Biophys. Res. Commun. pmid:21545791
Spiegel S and Milstien S The outs and the ins of sphingosine-1-phosphate in immunity. 2011 Nat. Rev. Immunol. pmid:21546914
Argraves KM et al. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. 2011 Lipids Health Dis pmid:21554699
Gu Y et al. Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway. 2011 J. Cell Biol. pmid:21555463
Oo ML et al. Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. 2011 J. Clin. Invest. pmid:21555855
Finney CA et al. S1P is associated with protection in human and experimental cerebral malaria. 2011 Mol. Med. pmid:21556483
Soleimani R et al. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. 2011 PLoS ONE pmid:21559342